Tesamorelin: GHRH-receptor pathway, the FDA-studied driver of visceral fat reduction
The ingredients inside weight loss patches are not approved medicines, and there is no credible evidence that the patches are safe or effective
Watch on YouTube
But the role of hyperinsulinemia driving CV events rather than blood glucose control is worthwhile investigating given UKPDS and other studies (micro vs macrovascular events)
There are many obesity-related complications, including type 2 diabetes, heart disease, obstructive sleep apnea, chronic kidney disease, non-alcoholic fatty liver disease, and cancer
For those ready to explore these benefits, our L-Citrulline with Maritime Pine Bark offers an excellent formulation that maximises nitric oxide support through complementary pathways